129 related articles for article (PubMed ID: 30387554)
41. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
42. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.
Kwiatkowski BA; Zielinska-Kwiatkowska AG; Bauer TR; Hickstein DD
Blood Cells Mol Dis; 2000 Feb; 26(1):84-90. PubMed ID: 10772879
[TBL] [Abstract][Full Text] [Related]
43. Ets factors regulate the polycystic kidney disease-1 promoter.
Puri S; Rodova M; Islam MR; Magenheimer BS; Maser RL; Calvet JP
Biochem Biophys Res Commun; 2006 Apr; 342(4):1005-13. PubMed ID: 16510125
[TBL] [Abstract][Full Text] [Related]
44. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
45. Discovery and synthesis of rocaglaol derivatives inducing apoptosis in HCT116 cells via suppression of MAPK signaling pathway.
Yang HJ; Li YN; Yan C; Yang J; Zeng YR; Yi P; Li YM; Hao XJ; Yuan CM
Fitoterapia; 2021 Jun; 151():104876. PubMed ID: 33675885
[TBL] [Abstract][Full Text] [Related]
46. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A; Tirode F; Cohen P; Delattre O
Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
[TBL] [Abstract][Full Text] [Related]
47. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
Blair DG; Athanasiou M
Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
[TBL] [Abstract][Full Text] [Related]
48. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
49. G-CSF induces stabilization of ETS protein Fli-1 during myeloid cell development.
Mora-Garcia P; Wei J; Sakamoto KM
Pediatr Res; 2005 Jan; 57(1):63-6. PubMed ID: 15557108
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
[TBL] [Abstract][Full Text] [Related]
51. Anticancer and multidrug-resistance reversing potential of traditional medicinal plants and their bioactive compounds in leukemia cell lines.
Senthilkumar R; Chen BA; Cai XH; Fu R
Chin J Nat Med; 2014 Dec; 12(12):881-94. PubMed ID: 25556059
[TBL] [Abstract][Full Text] [Related]
52. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
53. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.
Sakurai T; Kondoh N; Arai M; Hamada J; Yamada T; Kihara-Negishi F; Izawa T; Ohno H; Yamamoto M; Oikawa T
Cancer Sci; 2007; 98(11):1775-84. PubMed ID: 17727680
[TBL] [Abstract][Full Text] [Related]
54. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
[TBL] [Abstract][Full Text] [Related]
56. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
Polier G; Neumann J; Thuaud F; Ribeiro N; Gelhaus C; Schmidt H; Giaisi M; Köhler R; Müller WW; Proksch P; Leippe M; Janssen O; Désaubry L; Krammer PH; Li-Weber M
Chem Biol; 2012 Sep; 19(9):1093-104. PubMed ID: 22999878
[TBL] [Abstract][Full Text] [Related]
57. Antioxidant and apoptotic effects of Callistemon lanceolatus leaves and their compounds against human cancer cells.
Ahmad K; Hafeez ZB; Bhat AR; Rizvi MA; Thakur SC; Azam A; Athar F
Biomed Pharmacother; 2018 Oct; 106():1195-1209. PubMed ID: 30119188
[TBL] [Abstract][Full Text] [Related]
58. SRE elements are binding sites for the fusion protein EWS-FLI-1.
Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
[TBL] [Abstract][Full Text] [Related]
59. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
60. Anticancer effects of Ixeris dentata (Thunb. ex Thunb.) nakai extract on human melanoma cells A375P and A375SM.
Lee HN; Shin SA; Choo GS; Kim HJ; Park YS; Park BK; Kim BS; Kim SK; Cho SD; Nam JS; Choi CS; Jung JY
J Ethnopharmacol; 2016 Dec; 194():1022-1031. PubMed ID: 27836777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
